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Introduction A global rise in the incidence of adult obesity has occurred over the past 150 years, with a slow and steady increase prior to 1970 and a sharp rise between the years 1970 and 2000 (Bundred et al., 2001; Flegal et al., 1998 Flegal et al., , 2002 Flegal et al., , 2010 Ogden et al., 1997 Ogden et al., , 2006 Ogden et al., , 2007 . In spite of well publicized government guidelines, medical advice, and a proliferation of diet books, weight-watcher's programs, prescription diet pills, "fat-burning" herbs, and "appetite suppressing" supplements (Taubes, 2007) , the prevalence of obesity remains high. Despite recent reports by the news media that childhood obesity has decreased significantly in the last decade (e.g., Tavernise, 2014) , the Centers for Disease Control and Prevention (CDC) concludes that "Overall, there have been no significant changes in obesity prevalence in youth or adults between 2003-2004 and 2011-2012 . Obesity prevalence remains high and thus it is important to continue surveillance." This quote is from the same CDC report that provoked the optimistic news media headlines about the putative decrease in childhood obesity (Ogden et al., 2014) . Thus, more than a decade into the 21st century, the high incidence of obesity has not reversed (Ogden et al., 2013 (Ogden et al., , 2014 .
The relatively rapid rate of increase in body weight and the failure to reverse the high incidence of obesity present a challenging puzzle with many missing pieces. Some of the important pieces of this puzzle are in place, whereas others have yet to be fully appreciated and integrated with the other pieces.
For many years, the focus has been on three factors: Genetic influences, diet, and sedentary behavior. This review will emphasize three overlapping biological processes that interact with these factors: Sexual differentiation, maternal programming, and endocrine disruption. We begin with a very brief review of the role of genes, diet, and exercise, noting that global obesity patterns are not explained by these factors alone. Other evidence suggests the existence of widespread environmental obesogen acting on humans, laboratory rodents and nonhuman primates, domestic animals, and even feral animals. We therefore discuss endocrine disrupting compounds, natural and synthetic molecules from the environment that interfere with endocrine processes, including energy balance and ingestive behavior (Auwerx, 1999) . A clear understanding of their mechanism of action, however, requires that we understand sex differences in energy-balancing systems. In most species including our own, males differ from females in many energybalancing characteristics. Some of these sexual dimorphisms are behavioral in that they involve caloric intake, diet preferences, the rewarding aspects of food, and central nervous system circuits that control these behaviors. Other sexual dimorphisms are morphological and physiological; they involve the distribution of adipose tissue, adipocyte differentiation, glucose homeostasis, and other peripheral systems. We discuss the significance of these sex differences and the importance of understanding how these differences come about. This brings us to the process of sexual differentiation, the process whereby physiological traits are either masculinized or feminized by sex chromosomes, hormones secreted perinatally, hormones secreted during other critical periods of development (e.g., puberty), and interactions among these factors. Reproductive biologists have defined multiple mechanisms involved in sexual differentiation and experimental designs that discriminate among them, but few have been employed in obesity research. Some of these mechanisms involve fetal steroid receptor action, and endocrine disruptors act on these same receptors. Thus, experimental approaches used in sexual differentiation research will be critical in understanding the effects of endocrine disruptors on obesity.
Using a few well-designed studies as examples, we connect four new pieces of the obesity puzzle. First, endocrine disruptors are ubiquitous in the environment (Baillie-Hamilton, 2002; Colborn et al., 1993; Simonich and Hites, 1995) . Second, they affect energy balancing systems (Heindel, 2003; Mackay et al., 2013; Manikkam et al., 2013; Newbold et al., 2005; Oken and Gillman, 2003; Ruhlen et al., 2008; Skinner et al., 2013; Tracey et al., 2013; Vom Saal et al., 2012) . Third, energy balancing phenotypes are sexually dimorphic in humans, with the masculine phenotype most closely linked to metabolic diseases such as type II diabetes and heart disease (Bonora, 2000; Kotani et al., 1994; Lemieux, 2001; Macotela et al., 2009; Wajchenberg, 2000) . Fourth, endocrine disruptors have masculinizing effects on sexually dimorphic phenotypes, and might also act through other defined mechanisms of sexual differentiation (e.g., Mackay et al., 2013) . We also explain how peripheral changes in lipogenesis, lipolysis, and fuel oxidation bring about changes in ingestive behavior. The remainder of the review examines the consequences for future generations. New information on the epigenetic effects of endocrine disruptors, their overlap with fetal programming Skinner et al., 2013; Tracey et al., 2013) , and their potential for unmasking cryptic genetic variation (Ledon-Rettig et al., 2008 , 2009 provides plausible basis for hypothesizing that endocrine disruptors are responsible for the rapid increase in obesity at the end of the last millennium. Finally, we summarize and propose new research frontiers.
Genes, poor diet, and sedentary behavior cannot explain obesity
There is no doubt that genetic influences determine many aspects of energy balance, but does this mean that the rapid, sharp rise in human obesity can be explained by natural selection for obese phenotypes? We know of many single gene mutations that can influence various aspects of metabolism and ingestive behavior (Campfield et al., 1995; Farooqi et al., 1998; Geary et al., 2001; Halaas et al., 1995; Heine et al., 2000; Pelleymounter et al., 1995; Vaisse et al., 2000) . Yet, point mutations or major genes cannot account for a large proportion of the variance in body weight (Garver et al., 2013; Hinney and Hebebrand, 2008; Rankinen et al., 2006) . Human body weight is controlled by many genes that influence various aspects of body composition, eating behavior, and energy expenditure (Chaput et al., 2014) . The sharpest rise in human obesity spans only a few decades. Given the large population size, long generation time, and a lack of a strong selective advantage for obesity in humans (Speakman, 2006) , it seems unlikely that changes in gene frequencies alone can explain the recent sharp rise in global obesity.
Even studies aimed at documenting genetic influences on human obesity find strong evidence for the effects of diet and energy expenditure on body weight. The Quebec Family Study (QFS) was designed to estimate the extent of familial and genetic effects on energy balance using data from more than 700 families assessed between 1979 and 2002. The authors conclude that, "Unhealthy diet and physical inactivity are thus the two major factors … for obesity …. The influence of these "traditional" risk factors for obesity has been largely documented, including in the QFS." (Chaput et al., 2014) .
Diet alone is not a good explanation for the recent global rise in obesity because many individuals fail to gain weight on putative obesogenic diets. In human or nonhuman animal populations, some individuals are predisposed toward body fat accumulation when exposed to obesogenic diets or after they end a period of calorie restriction, whereas other individuals are resistant to body weight gain under the same conditions (e.g., Akieda-Asai et al., 2013; Blundell and Cooling, 2000; Jackman et al., 2006; Ji and Friedman, 2007; Ji et al., 2005; Levin et al., 1987; Mutch et al., 2011; Pierce et al., 2010; Schemmel et al., 1970; Schmidt et al., 2013; and reviewed by Astrup, 2011; Blundell and Cooling, 1999; Levin, 2009) . One explanation is genotype × environment interaction (e.g., Bouchard and Tremblay, 1990; Garver et al., 2013; Levin, 2009; Madsen et al., 2010; Martinez et al., 2003; Novak et al., 2006 ). Yet, in many populations, even those individuals on the lower end of the body weight spectrum are beginning to gain weight (Lustig, 2006) . Thus, if there is a susceptible phenotype, we must ask, "Is the incidence of this susceptible phenotype on the rise, and if so, why?"
In this regard, it is important to note that rises in the rates of obesity are not restricted to human populations, but also include domestic cats, dogs, horses, and laboratory rodents and nonhuman primates (German, 2006; Klimentidis et al., 2011; Raffan, 2013; Thatcher et al., 2009) . It is safe to assume that these nonhuman animals are not victims of corporate marketing. Furthermore, the rises in obesity include laboratory animals fed the "control" diets that formerly did not support current rates of body weight gain. It might be argued that pet and lab animal obesity is accounted for by a sedentary existence in small, confined spaces. This, however, does not explain the next piece of the puzzle: obesity in wildlife. Recent data have emerged documenting obesity in feral animals that are not confined to cages or homes, but are free to roam (Klimentidis et al., 2011; Wingfield, 2008) . This suggests that there might be agents in the environment that have widespread obesogenic effects on many different species.
Introduction to endocrine disruptors
The book Our Stolen Future brought world-wide attention to the fact that many natural and synthetic molecules interfere with endocrine processes acting as toxins to animals that come in contact with them (Colborn et al., 1997) . These endocrine-disrupting compounds typically bind to hormone receptors, thereby mimicking or blocking hormone action. The best-known example might be the devastating effects of DDT (dichlorodiphenyltrichloroethane) on populations of bald eagles (Bowerman et al., 1995; Colborn, 1991) . In this case, a synthetic molecule from a commonly used pesticide caused a rapid decline in reproductive success, largely by mimicking the action of estrogens binding to estrogen receptors (ERs). After four decades of study, it is clear that there are many different endocrine disruptors that interfere with estrogen, androgen, thyroid, or glucocorticoid action, with related effects on steroid biosynthesis, steroid sensitive neurotransmitter systems, hormone degradation and/or elimination, reproductive development, and behavior ( Fig. 1, reviewed by Gore, 2008) . Estrogenic compounds include polychlorinated biphenyls (PCBs), components of coolants, insulators, plasticizers and flame-retardants. Similarly, phytoestrogens such as genistein, pesticides like DDT, and compounds that leech from plastic containers such as bisphenol A (BPA) are estrogenic. Phthalates, used as plasticizers, tend to be androgen receptor (AR) antagonists, although some are clearly estrogenic. These are just a few of many examples. Effects of endocrine disruptors on the mammalian reproductive system include but are not limited to inhibited spermatogenesis and ovulation, cryptorchidism, hypospadias, decreased semen quality, premature ovarian failure, polycystic ovary syndrome (PCOS), endometriosis, accelerated puberty, masculinized genitalia in genetic females, feminized yolk production (vitellogenesis) in males, initiation of mitosis in estrogen sensitive breast cancer cells, disrupted hypothalamic-pituitary-gonadal function, altered sex and social behavior, and these have been reviewed previously (Balabanic et al., 2011; Frye et al., 2012; Gore, 2008 Gore, , 2010 Gore and Patisaul, 2010; Nordkap et al., 2012; Ottinger and Dean, 2011; Ottinger et al., 2001 Ottinger et al., , 2005 Ottinger et al., , 2008 Patisaul, 2005 Patisaul, , 2013 Patisaul and Polston, 2008) . Each of these individual effects on reproductive processes can have negative fertility outcomes that diminish population size and threaten entire species, and the cumulative effects are often devastating.
Endocrine disruptors come from many and varied sources (BaillieHamilton, 2002; Colborn et al., 1993; Simonich and Hites, 1995) . They are found in organic pesticides, perfumes, and solvents that are released into the air. They include molecules in industrial effluent. They include chemicals used to make containers like plastic water and baby bottles. These containers leech their endocrine disrupting byproducts into the ingestible contents of those containers. In addition, many different cleaning products, paints, and glues contain molecules that act as endocrine disruptors (reviewed by Baillie-Hamilton, 2002; Balabanic et al., 2011; Crews et al., 2000; Gore, 2010; Gore and Patisaul, 2010; Khanal et al., 2006) . Some endocrine-disrupting compounds are simply steroid hormones, for example, humans and livestock excrete natural and prescription steroids and other pharmaceutical products that make their way into water supplies, and at concentrations above the natural levels, these steroids bind to mammalian hormone receptors altering physiology and development (reviewed by Frye et al., 2012; Gore, 2010) . Endocrine disrupting compounds also include natural isoflavones from soy and other plants that are eaten by adults, children, and infants (reviewed by Patisaul, 2005 Patisaul, , 2013 . These many and varied sources can make it difficult to estimate the contribution of any one endocrine disrupting compound to changes in reproduction and energy balance, but this difficulty does not diminish the importance of understanding the mechanisms.
There is general agreement that increasing exposure of humans and wildlife to endocrine-disrupting compounds is a major societal problem that requires a concerted interdisciplinary focus that includes cooperation among behavioral neuroendocrinologists, reproductive biologists, conservation biologists, clinicians, epidemiologists, ecologists, evolutionary biologists, molecular biochemists as well as scientists and policy-makers in other disciplines Crews and Gore, 2011; Gore et al., 2014; Vandenberg et al., 2013; Zoeller et al., 2012) . We argue that this interdisciplinary focus must include scientists that specialize in neuroendocrinology of ingestive behavior, energy balance, and obesity.
Endocrine disruptors, ingestive behavior, energy balance, and obesity
The idea that endocrine disruptors affect energy balance is not new. An insightful review by Baillie-Hamilton points out that in the 1970s and 80s, a plethora of endocrine disrupting agents were found to induce body weight gain, although they were categorized by toxicologists as "nontoxic," even at high doses (Baillie-Hamilton, 2002) . The number of these obesogenic agents is astounding, but largely unknown because the body weight data are not mentioned in the abstracts (they are reported only within the article). In fact, in some of these articles, the fact that the compounds promoted body weight gain was cited as evidence that the compounds promoted good health (reviewed by Baillie-Hamilton, 2002) .
Evidence is accumulating that endocrine-disrupting compounds influence many aspects of energy balance, and in some cases, these affected traits are known to lead to obesity and/or diabetes (reviewed by Gore, 2010; Heindel, 2003; Newbold et al., 2005; Vom Saal et al., 2012) . Increases in body weight and body fat content, altered adipocyte differentiation, disrupted glucose homeostasis, obesity and insulin resistance all result from perinatal treatment with endocrine disruptors such as the synthetic estrogen, diethylstilbestrol (DES), the soy isoflavone, genistein, or the ER-binding molecule known to leach from plastics and paints, BPA (Masuno et 2008 ; Sakurai et al., 2004) . The variety of effects and mechanism of action on energy balance are as varied as those on reproduction.
The effects of endocrine disruptors differ with different stages of development. The most pronounced effects, at the lowest concentrations, occur during fetal development, when endocrine disruptors make permanent changes that determine adult physiological and behavioral function. Endocrine disruptors cross the placenta, i.e., they are transferred across the fetal-maternal blood barrier and are present in breast milk (Alleva et al., 1998; Bordet et al., 1993; Jacobson and Jacobson, 1996) . In some cases, transient exposure to endocrinedisrupting compounds during fetal development affects reproductive traits in adults, which persists and leads to obesity in successive (e.g., the F 3 ) generations, even though the endocrine-disrupting compound is no longer present in the environment Skinner et al., 2013; Tracey et al., 2013) .
Perinatal effects of endocrine disruptors are likely to interfere with key steps in the development of sex differences. Endocrine disruptor action involves the perinatal action of androgens, estrogens, and glucocorticoids on their cognate receptors. Understanding the natural process of sexual differentiation has been key to understanding the effects of endocrine disruptors on development of the sexually dimorphic reproductive system. Because energy-balancing traits are sexually dimorphic, understanding sexual differentiation is likely to be critical for understanding endocrine disruptor effects on energy balance.
Sexual dimorphisms of the energy balancing traits
Sexual dimorphisms in energy balance are not just an interesting aside or incidental tangent to the study of energy balance. Sexual differentiation is an essential puzzle piece that must be integrated into the bigger picture of energy balance. We have known about sex differences in body composition since the beginning of behavioral endocrinology (Berthold, 1849) , and we know that these differences are in part due to the effects of testicular androgens on body fat storage and muscle development (Pasquali, 2006; Siegel et al., 1981; Symeon et al., 2010) . These effects, however, are not explained by activational effects of adult hormones in all species. For example, in cattle, it is clear that peripubertal androgens increase growth and muscle development (Tucker and Merkel, 1987 ), yet castrated bulls (steers) grow faster than adult females (heifers), and there are species differences in the sexual dimorphism. The adult presence of androgens vs. estrogens cannot explain these phenomena. These sexual dimorphisms in growth and morphology are of great interest in the meat and dairy industry, and have revealed a plethora of sexual dimorphisms, such as those found in growth hormone concentrations, insulin-like growth factor, and somatotrophin release-inhibitory factor (reviewed by Gatford et al., 1998) . Sexual dimorphisms and their link to reproductive success will be central to understanding the difference between healthy energy balance and unhealthy energy balance.
Androgens, adiposity, and disease are interrelated, particularly in humans. Men, on average have higher circulating androgen concentrations and are larger than women. What is more important, they tend to accumulate white adipose tissue (WAT) in the visceral, abdominal region, whereas women tend to accumulate WAT subcutaneously, particularly in the gluteofemoral region, i.e., the hips and thighs (Kotani et al., 1994) . This is reflected in the waist-to-hip ratio, which is significantly higher in men than in women. Male-typical (android) but not female-typical (gynoid) WAT distribution is linked to many negative health consequences (Wajchenberg, 2000) , even in the absence of obesity, including insulin and leptin resistance (Bonora, 2000; Lemieux, 2001; Macotela et al., 2009) , type II diabetes (Lundgren et al., 1989) , cardiovascular disease (Kissebah et al., 1982; Krotkiewski et al., 1983) , hypertension (van Lenthe et al., 1998) , and inflammation . The gynoid WAT distribution is not associated with these negative health consequences. This is partially because subcutaneous WAT, more prevalent in females, has a very different cytoarchitecture than the visceral WAT, more prevalent in males. Subcutaneous WAT and visceral WAT also differ in lipid flux and storage capacity (Power and Schulkin, 2008) , and furthermore, visceral WAT accumulation is linked to elevated inflammation (reviewed by Bloor and Symonds, 2014) . The link between android, masculine obesity and disease has moved researchers to venture beyond the body mass index (BMI, a measure of body weight as a function of height) to look in more detail at adipose tissue distribution and morphology.
Unlike android WAT, the gynoid WAT distribution is critical for successful lactation because breast milk production is fueled by fatty acids released from lipids stored in the mother's gluteofemoral WAT. In fact, the hormones secreted prior to lactation promote the growth of gluteofemoral WAT; the hormones secreted during lactation promote the breakdown of those lipids and the release of fatty acids used in breast milk production (Rebuffe-Scrive et al., 1985) . At least some investigators agree that the size of the gynoid WAT is not associated with negative health consequences, even in women whose BMI places them squarely in the obese range of the BMI population distribution (Bjorntorp, 1988; Despres, 1993; Gillum, 1987; Macor et al., 1997; Marin and Bjorntorp, 1993; Power and Schulkin, 2008; Van Gaal et al., 1988) . In fact, subcutaneous gluteofemoral WAT might be cardioprotective (Van Pelt et al., 2005) , and this protection might wane along with a rise in visceral fat accumulation with age or with the number of years past menopause (Kotani et al., 1994; Lovejoy et al., 2008) . Related to these cardioprotective and prolactational effects, the sexual dimorphisms in WAT distribution might have played a role in mate selection during human evolution. In support of this idea, crosscultural studies show that men tend to rate women as more attractive if they have a low, rather than a high waist-to-hip ratio, regardless of body weight (Jasienska et al., 2004; Singh, 1993 Singh, , 1994a Singh, ,b,c, 2002 . Nevertheless, we can no longer afford to overlook the association of these sex differences in adipose tissue distribution with sex differences in disease.
If sex differences in body fat composition and distribution are due to sex differences in adult gonadal hormones, it would be expected that visceral obesity and its metabolic sequelae could be ameliorated by adult treatment with gonadal hormones. To the contrary, exogenous treatment with testosterone in adult men has yielded disappointing results with regard to levels of circulating triglycerides, glucose tolerance, insulin sensitivity, and visceral abdominal obesity (i.e., there was either no effect or a positive effect on endocrine profiles) (Wu and von Eckardstein, 2003) . Thus, it is unlikely that negative effects of sex hormones on metabolic parameters can be explained by differences in adult hormone concentrations. This reiterates the need for more attention to peripubertal and perinatal hormone effects on energy balance.
In addition to the above-mentioned sex differences, there are well documented sex differences in energy expenditure, orosensory physiology (which affects the taste and smell of food), and normal and disordered ingestive behaviors (reviewed extensively by Asarian and Geary, 2013) . In most vertebrates, males differ from females in daily food intake (Wade and Gray, 1979) , preference for sweet and creamy flavors (Bartoshuk, 1978; Prutkin et al., 2000; Zucker, 1969) , binge eating , susceptibility to diet-induced obesity (Jones et al., 1986) , energy restriction-induced hyperphagia (Nohara et al., 2011; Shi et al., 2008) , energy restriction-induced decreases in energy expenditure (Nohara et al., 2011; Shi et al., 2008) , resistance to leptin-and insulin-induced hypophagia (Clegg et al., 2006) , resistance to ghrelin-induced hyperphagia (Clegg et al., 2007) , glucoor lipoprivation-induced hyperphagia (Sandoval et al., 2012) , proopiomelanocortin (POMC) gene expression in the arcuate nucleus of the hypothalamus (ARH) (Nohara et al., 2011) , seasonal food intake responses to energetic challenges and leptin (Clarke, 2001; Clarke et al., 2001) , the tendency to develop obesity in response to exposure to high-intensity sweeteners (e.g., saccharin) (Swithers et al., 2013a, b) , and many other traits (reviewed by Asarian and Geary, 2013; . These data suggests that we examine the sexual differentiation of energy balancing traits with the same rigor that we examine sexual differentiation of reproductive traits.
Furthermore, these data pique a number of important questions. Which came first, the unmanageable appetite and overeating, the increased visceral WAT accumulation, or the decreased energy expenditure? Are these effects rooted in the origins of sex differences? Are these traits also influenced by endocrine disruptors?
Sex chromosomes and energy balance
Investigators interested in the origins of obesity will be aided by a better understanding of the process of sexual differentiation (Fig. 2 ). Sex differences arise by genetic, hormonal, and environmental effects and the interaction among these factors (reviewed by Lenz et al., 2012) .
The initial steps are related to the presence or absence of genes on the Y chromosome. The undifferentiated genital ridge, for example, develops into the testis in the presence of the Sry gene and into the ovary in its absence. Aspects of body weight and energy metabolism are affected directly by genes on the Y chromosome and indirectly by hormones secreted by the testis (Chen et al., 2013) .
With regard to energy balancing characteristics in mammals, genes on the X and Y chromosomes are important. The presence of sex chromosomes can act independently of gonadal hormones to influence adiposity, food intake, fatty liver disease, and glucose homeostasis, and at least some of these effects are mediated by differential gene dosage that results from X chromosomes that escape inactivation Chen et al., 2012) . Experimental techniques are available for producing mice that are gonadally male (they have functional testes) with the female sex chromosome complement (XX) and mice that are gonadally female (with functional ovaries) with the male sex chromosome complement (XY). Mice of either gonadal sex with two X chromosomes have significantly greater body weight, adiposity, and food intake during the light portion of the day compared to those with only one X chromosome. Consistent with this result, XXY mice are heavier, fatter, and more hyperphagic than XO mice. The mechanism whereby X chromosome dosage influences these traits is under investigation and appears to involve the orexigen, growth hormone (GH) ( Bonthuis and Rissman, 2013) . Gonadal females with 2 X chromosomes have higher levels of GH gene (Gh) expression in the brain compared to gonadal females with 1 X chromosome and to gonadal males (XY). Furthermore, Gh expression in the brains of mice with 2 X chromosomes is significantly correlated with body weight. Acute infusion of GH into the brain region of GH receptors causes significant increases in food intake in normal (XY) males. This information about the mechanisms that underlie the effects of X-chromosome dosage on adiposity and food intake might be critical to understanding environmental effects on obesity, as GH is a potential target for endocrine-disrupting compounds (Elango et al., 2006) .
The organizational hypothesis and energy balance
In addition to X chromosome-mediated sex differences, some sexually dimorphic energy-balancing-traits are influenced by hormones secreted perinatally, including thyroid hormone, glucocorticoids, and gonadal steroids. The organizational hypothesis of sexual differentiation posits that sex differences arise in two significant endocrine steps (Fig. 2) . In the first step, fetal hormones permanently organize the brain and periphery. In the second step, peripubertal and adult increases in hormones activate these masculinized substrates. This was first demonstrated in mammalian genital development (reviewed by Blaschko et al., 2012) . It is important to note this two-part process because adult exposure to testosterone will have different effects on the brain and body, depending on the level of perinatal exposure to testosterone. Thus, early masculinization or feminization (or X chromosome dose) prepares or "primes" the tissue to respond to gonadal hormones during later periods of development.
Following experiments that demonstrated prenatal organization of the genitalia, classic experiments from the 1960s and 70s revealed that sexual dimorphisms in rodent sex behavior are organized neonatally and activated in adulthood by hormones secreted beginning at the time of puberty (Feder et al., 1966; Grady et al., 1965; Pfaff and Zigmond, 1971; Phoenix and Chambers, 1982; Phoenix et al., 1959; Phoenix et al., 1983) . This moved the study of sexual differentiation out of the genitals and into the brain and behavior.
In parallel with the research on sexual differentiation of reproductive behavior, this two-part process was found to underlie sex differences in food intake and body weight. Just as male-typical sex behavior is more prevalent in male than in female rats, body weight and food intake are greater in male rats (Aschkenasy-Lelu and Aschkenasy, 1959) . In rats, male-typical sex behavior, food intake, and body weight are all decreased by adult castration and the effect is reversed by testosterone replacement. Furthermore, adult gonadectomy significantly decreases the incidence of sex behavior and increases body weight and food intake in females and has the opposite effects in males (Gentry and Wade, 1976; Kakolewski et al., 1968) . Analogous to male-typical sex behavior, adult food intake is more responsive to the stimulatory effects of adult testosterone treatment in males and neonatally androgenized females than in nonandrogenized females (Bell and Zucker, 1971 ). In addition, adult food intake is less responsive to the suppressive effects of estradiol in males and neonatally androgenized females than in nonandrogenized females (Gentry and Wade, 1976) . This early work lays the foundation for perinatal androgens and their masculinizing effects on the neural circuits that control food intake and body weight and for the study of sexual differentiation for the energy balancing system.
The masculinizing effects of perinatal androgen treatment have been compared to perinatal exposure to endocrine disruptors, but the second step is often omitted (i.e., adult response to steroid treatment is not tested). It will be instructive to determine whether perinatal exposure to endocrine disruptors organizes or primes the brain to respond to adult hormones. This pattern of perinatal steroid organization of behavior and physiology underlies many aspects of sexual, social, cognitive, and ingestive behaviors in vertebrates (Arnold and Gorski, 1984;  MacLusky and Naftolin, 1981; Morris et al., 2004; Negri-Cesi et al., 2004 Wu et al., 2009 ). The concepts of sexual differentiation of the gonad apply to brain and behavior, including food intake and body weight, yet, relatively few ingestive behavior and obesity researchers have employed experimental designs used in the study of sexual differentiation.
The aromatization hypothesis, multiple critical periods, and energy balance
In more recent years, the organizational hypothesis has been augmented to include the aromatization hypothesis, the idea that testosterone masculinizes brain and behavior only after it is aromatized to estradiol in the brain (Davidson et al., 1968; Vagell and McGinnis, 1997) . One tenant of the aromatization hypothesis is that females are normally protected from the masculinizing effects of their mother's estradiol by molecules that bind estradiol, such as alpha fetal protein (in the case of rodents) and sex-hormone binding globulin (in the case of primates) (Bakker et al., 2006) . Thus, the sexual dimorphism in the prenatal circulating steroid profile (high testosterone in males but not in females) results in estradiol action in male but not in female rodent brains. Females lack these high levels of prenatal androgens, and are protected from the action of circulating estradiol. According to the synaptocrine hypothesis (part of the aromatization hypothesis) the presence of aromatase at only some critical synaptic junctures confers the ability to control brain function via estradiol action in some brain nuclei while simultaneously conferring other functions via androgen action in other brain nuclei Saldanha et al., 2011) .
Another revelation was that the perinatal period was not the only time when the brain is permanently organized, and that full expression of female-typical behaviors requires active feminization by hormones. It was at first tempting to refer to the female as the "default" sex, given the fact that feminization and demasculinization require an absence of androgens. This is incorrect, however, since full feminization and/or demasculinization also requires estradiol action, albeit at a different time period and in smaller amounts (Bakker et al., 2002) . In other words, the absence of testosterone is not enough to produce a female; females are not merely the default sex.
The perinatal period is not the only time window that is critical for permanent organization of sexually dimorphic characteristics. Adult female-typical sex behaviors are restored in mice lacking aromatase by treatment with low levels of estradiol during postnatal days 15 and 25, but not before postnatal day 15 (Brock et al., 2011) . Thus, complete feminization requires not only the absence of testosterone perinatally, but also the action of estradiol prepubertally. There is mounting evidence that complete sociosexual development requires gonadal steroid action peripubertally in many mammalian species including our own (Juraska et al., 2013) .
At least two examples from the energy balance literature support the idea that there are multiple critical periods in which hormones organize energy-balancing traits (Fig. 2) . First, there is a sexual dimorphism in the eating response to deficits in metabolic fuel availability in rats. Deficits in metabolic fuel availability are induced by treatment with mercaptoacetate (MA), an inhibitor of fatty acid oxidation. Males, but not females show significant increases in food intake in response to MA treatment (Swithers et al., 2008) . Adult ovariectomy fails to ameliorate the sex difference, whereas peripubertal ovariectomy masculinizes the food intake response to MA treatment. Treatment of prepubertallyovariectomized females with estradiol reverses the effects of ovariectomy (Swithers et al., 2008) . These experiments identify the peripubertal period as an additional time window when sexual dimorphic ingestive behaviors are established.
Does the aromatase hypothesis apply to ingestive behavior development? There is a sexual dimorphism in the tendency to overeat and gain weight when exposed to high-intensity sweeteners, such as saccharin. Male rats, whether they are obesity prone or not, readily become hyperphagic and overweight in response to saccharin relative to glucose supplemented diets. Female rats that are not obesity-prone are resistant to the hyperphagia and weight gain induced by the saccharin supplement (Swithers et al., 2013a) . Adult ovariectomy fails to ameliorate the sex difference in resistance to hyperphagia in response to the high-intensity sweetener. However, the sex difference is abolished by adult treatment with aromatase, suggesting that the normal, obesityresistant female is actively feminized by local estrogen action. There might also be some pubertal programming of the response to highintensity sweeteners because when the ovaries are surgically removed prior to the onset of puberty, females are masculinized; i.e., females are not resistant to obesity and overeating induced by the high-intensity sweetener (Swithers et al., 2013a) . The results suggest that the female tendency to be resistant to the obesogenic effects of high-intensity sweeteners is actively feminized peripubertally and involves the conversion of testosterone to estradiol in localized cells in adulthood (Fig. 2) .
Endocrine disruptors, sexual differentiation, brain, and behavior
Since the classic experiments on the prenatal organization of body weight and food intake in the 60s and 70s, many sex differences in ingestive behavior have been noted, yet relatively few of these have been traced to organizational effects. Even fewer have been examined with reference to perinatal aromatization, synaptocrine action, or active feminization.
Recent attention has turned to the effects of perinatal gonadal steroids on the neural circuitry of ingestive behavior. Male mice have a significantly higher daily food intake than female mice throughout life. In addition, they show higher levels of postfast hyperphagia and a higher sensitivity to leptin-induced hypophagia compared to female mice (Nohara et al., 2011) , and these behavioral sex differences have been linked to sexual dimorphisms in the arcuate nucleus of the hypothalamus (ARH).
The ARH has received a great deal of attention as a primary controller of ingestive behavior in response to metabolic fuel availability, insulin, leptin, and ghrelin (reviewed by Barsh and Schwartz, 2002; Crowley et al., 2001; Schwartz and Porte, 2005; Zigman and Elmquist, 2003) . Despite this intense focus, it should be mentioned that ingestive behavior is known to be controlled by a distributed neural network that includes peripheral sensors of metabolic fuel availability and nutrient intake, the caudal brain stem, midbrain, hypothalamus, and other areas including the nucleus accumbens, ventral tegmental area, and amygdala (reviewed by Grill, 2010; Grill and Hayes, 2009 ). In the ARH, however orexigenic effects of neuropeptide Y (NPY) and agoutirelated protein (AgRP) are thought to be counterbalanced by the anorectic peptides: cocaine and amphetamine-regulated transcript (CART) and alpha-melanocyte-stimulating hormone (α-MSH), a cleavage product of the proopiomelanocortin (POMC) gene. Metabolic challenges tend to increase NPY and AgRP gene expression and secretion while simultaneously decreasing these parameters in POMC cells. These changes can be reversed by re-feeding or by treatment with the adipocyte hormone leptin (reviewed by Schwartz and Porte, 2005; Zigman and Elmquist, 2003) . Peripheral hormones affect not only the release of neuropeptides but also the synaptic input into NPY/AgRP and POMC/CART cells (reviewed by Briggs and Andrews, 2011; Eckel, 2011; Gao et al., 2007; Gyengesi et al., 2010; Zigman and Elmquist, 2003) .
Relevant to the topic at hand, there is a sexual dimorphism in the number of ARH cells that contain NPY, AgRP, and POMC (Nohara et al., 2011) . Male rats show significantly lower POMC gene expression and neuronal projections from POMC cells to the ARH compared to females. Perinatal androgens masculinize the sexually dimorphic circuits of the ARH. The daily food intake, postfast hyperphagia, and POMC gene expression and projections are fully masculinized in females treated with either testosterone or dihydrotestosterone (DHT), both of which act via the ARs. This is consistent with the organizational hypothesis, the idea that testosterone masculinizes the energy balancing system during early development via action on AR in the ARH (Nohara et al., 2011) .
What about the aromatization hypothesis and ARH circuitry? There is a sexual dimorphism in the eating response to leptin treatment. Males are less resistant than females to leptin-induced hypophagia. Females neonatally treated with testosterone or estradiol, but not DHT, are not masculinized, but are instead ultra-feminized; they show higher resistance to leptin-induced hypophagia (Nohara et al., 2011) . Leptininduced hypophagia appears to be actively feminized by estradiol. These data support the aromatization hypothesis and confirm that different aspects of the energy balancing system are masculinized or feminized by different steroid hormones acting on different steroid receptors (Fig. 2) .
Missing from these studies are data that address the questions, "How do neonatal steroids prime the animals to respond to adult estradiol and testosterone?" The mice in the above-mentioned experiments were not gonadectomized in adulthood and were not treated with controlled levels of gonadal steroids in adulthood. Are these ARH systems analogous to those that control lordosis, i.e., Do perinatal hormones program these ARH systems to respond to peripubertal and adult hormones? Are the effects on the ARH and ingestive behavior secondary to the changes in body fat accumulation that were induced by the steroid treatment? Are there sexual dimorphisms outside the ARH?
These patterns are not limited to rodents. The body weight, insulin sensitivity, POMC, and AgRP systems are also sexually dimorphic in sheep. Males are larger, are more prone to develop insulin-resistance, and show a higher number of AGRP-immunoreactive (ir) cells compared to POMC-ir cells. Prenatal testosterone inhibits growth of the fetal lamb, leading to postnatal catch-up growth (Manikkam et al., 2004) and decreased insulin sensitivity in adulthood (Recabarren et al., 2005) . Prenatal testosterone masculinized the ARH nucleus of the adult ewe (Sheppard et al., 2011) . Adult ewes that had received prenatal testosterone treatment showed a significantly higher number of AgRP-ir cells compared to POMC-containing cell bodies and fibers in the median ARH. The effects of testosterone treatment were mimicked by prenatal treatment with DHT and prevented by co-treatment with an antagonist to AR. Perinatal androgen treatment also increased the density of AgRP fiber-ir in the preoptic area, paraventricular nucleus of the hypothalamus (PVH), lateral hypothalamus (LH), and dorsomedial hypothalamus (DMH). These data show that in sheep, the cells that contain AgRP and their projections are masculinized during prenatal development by androgens acting on the AR. These effects in sheep are similar to the effects of neonatal testosterone in mice, except that, in mice, androgens were acting on the POMC rather than on the NPY/AgRP system (Nohara et al., 2011) .
In Sheppard et al.'s (2011) study, all ewes were ovariectomized and treated with a consistent dose of estradiol in adulthood, thus controlling for any possible secondary effect of neonatal treatment on endogenous ovarian function. It is not known, however, whether prenatal testosterone primes the brain to respond to adult hormones in sheep. In addition, we do not know whether there is active feminization of the adult response to ovarian steroids in sheep. Again, we do not know whether effects in the ARH are secondary to changes in body composition.
The relevance of sexual differentiation research to understanding human health and disease is not in doubt. For example, prenatal androgens masculinize body fat distribution, insulin resistance, and ingestive behavior. By measuring traits in opposite sex twins compared to samesex twins, researchers can estimate the extent of exposure to prenatal androgens (Culbert et al., 2013) . Females from opposite-sex twin pairs are exposed to more prenatal testosterone from their male twin. Women with a male twin have a significantly higher BMI and rate of dyslipidemia compared with women with a dizygotic female twin (Alexanderson et al., 2011) . A similar conclusion is drawn from studies that use finger length ratio to estimate prenatal androgen exposure. The length of the index finger (the second digit) to the length of the ring finger (the fourth digit) is sexually dimorphic; males and prenatally androgenized females have a lower second to fourth digit ratio (a.k.a., 2D:4D) (Brown et al., 2002; Gobrogge et al., 2008) . As would be expected if prenatal androgen exposure masculinizes the body fat distribution, 2D:4D ratio is negatively correlated with waist-to-hip ratio in humans (Fink et al., 2003) .
In addition, sex differences in disordered eating are influenced by prenatal androgens in human beings. Men tend to score lower than women on psychological scales that measure the tendencies toward disordered eating. When tested during puberty, females from opposite-sex twin pairs showed more masculinized levels of disordered eating than females from same-sex twin pairs. These associations with the twin were independent of other variables, such as BMI and anxiety levels, since binge eating can occur at extremes in body weight (both in women with anorexia nervosa and with obesity). These data are consistent with the idea that prenatal androgens masculinize some aspect of the energy balancing system so that men are to some degree buffered from, but women are at a higher risk for developing eating disorders (Culbert et al., 2013) .
A few studies have emerged demonstrating that endocrinedisrupting compounds can masculinize or feminize energy balancing traits. For example, perinatal exposure of rats to BPA masculinizes some aspects of the energy balancing neural circuits via ER, but has other effects that are not masculinizing and might be independent of ER (MacKay et al., 2013) . This suggests that the sexual dimorphisms in rat energy balance are partially explained by the aromatization hypothesis. This effect is mimicked by perinatal exposure to BPA. Pregnant and lactating mice fed diets that contained either a low or a high dose of BPA, a vehicle, or the estrogenic endocrine disruptor, DES, were allowed to grow to adults and their energy balancing traits were examined in detail. Offspring were weaned initially onto a normal laboratory chow diet, then as adults they were exposed to either a normal or an energetically-dense diet (MacKay et al., 2013) . Females exposed to the high dose of BPA, but not those exposed to DES show a masculinized propensity for diet-induced obesity, with increased levels of body weight, WAT gain, and increased levels of food intake compared to untreated females fed the same high-energy diet. Furthermore, BPAtreated but not DES-treated females on a high-energy diet show masculinized plasma leptin concentrations, ARH POMC projections, and ARH ER expression i.e., significantly increased plasma leptin concentrations, reduced POMC mRNA expression in the ARH, and increased ER expression in the ARH. By contrast, males exposed to the high dose of BPA, but not those exposed to DES show impaired glucose tolerance on both high-energy and low-energy diets. They also show reduced ARH POMC projections to the PVH. When exposed to energetically-dense diets, BPA treated males show greater NPY/AgRP expression in the ARH. In sum, exposure to BPA but not to DES hypermasculinizes males masculinizes females and these effects appear to be independent of ER (Fig. 2) . In addition, BPA has other effects that cannot be described as masculinizing, but these experiments did not manipulate the response to adult hormones (testosterone vs. estradiol plus progesterone) (Mackay et al., 2013) . Furthermore, there is still a question as to whether changes in the ARH are secondary to or independent of changes in lipid accumulation or other peripheral factors.
Endocrine disruptors, sexual differentiation, and peripheral factors
Most work on prenatal steroids, endocrine disruptors, and obesity is focused on peripheral factors, especially glucose homeostasis, lipid profiles, adipose tissue distribution, and adipocyte differentiation, which can presumably lead to differences in overall energy expenditure and body fat distribution. In rats, perinatal androgen exposure, for example, increases body weight and visceral adiposity; serum insulin, triglyceride, and cholesterol concentrations; hepatic triglyceride content; and in some studies increased insulin resistance (Demissie et al., 2008) . Similar treatments lead to impaired insulin sensitivity and secretion and increased visceral adiposity in monkeys (Bruns et al., 2004; Eisner et al., 2003) , and reduced birth weight and impaired insulin resistance in sheep (Fig. 2, Recabarren et al., 2005) .
Again, BPA serves as a prime example of an endocrine disruptor that influences body weight, adipocyte differentiation, and adipocyte accumulation in specific tissues via action on the ER (Chamorro-Garcia et al., 2012; Kendig et al., 2012; Lalles, 2012; Liu et al., 2012; Marmugi et al., 2012; Nadal, 2013; Polyzos et al., 2012; Ronn et al., 2013; Shankar et al., 2012; Taxvig et al., 2012; Trasande et al., 2012; Vom Saal et al., 2012; Wang et al., 2012a Wang et al., , 2012b Wens et al., 2013; Zhao et al., 2012 and reviewed by Vom Saal et al., 2012) .
The data are not confined to nonhuman animals. In human populations there is a positive correlation between levels of urinary BPA and obesity across gender, race, and ethnicity, independent of potential confounding factors including, smoking, alcohol consumption, and serum cholesterol levels (Shankar et al., 2012) .
Studies in laboratory animals suggest a mechanism of action. Endocrine disruptors appear to affect growth of "preadipocytes," undifferentiated cells that will eventually develop the gene expression patterns and metabolic characteristics of an adipocyte, such as the ability to store triglycerides in lipid droplets. One ER-binding molecule, for example, 4-nonylphenol, inhibits this process, whereas BPA stimulates this process. The effects of BPA differ depending on the timing of fetal exposure to those compounds and the energy availability via the mother's energy balance (Masumo et al., 2002) . Nevertheless, these changes in the adipocyte lead to changes in energy expenditure, storage, and intake are increased or decreased.
Once the WAT and other cell types (muscle, liver, and brown adipose tissue (BAT)) are formed, energy expenditure in those cells can be influenced by many different transcription factors, including estrogen, androgen, thyroid, and glucocorticoid receptors. Transcription factors are molecules that interact with DNA to change which genes are transcribed and how often. For example, ER-α is a ligand-dependent transcription factor that binds to a segment of DNA on genes known as the estrogen-receptor-response element (Iwase, 2003; Muramatsu and Inoue, 2000) . The number of known ligand-dependent transcription factors is growing to the point that they have been grouped together as a superfamily-a group of approximately 150 members encoded by at least 48 unique human genes (Brinkmann, 2011; Clark and Belvisi, 2012) . Those with particular relevance are the retinoic acid receptors (retinoic acid receptors, RARs and retinoid X receptors, RXRs), and the peroxisome proliferator-activated receptors (PPARs), and numerous orphan receptors (Kliewer et al., 2001; Redonnet et al., 2001) . PPARs, for example, are activated by fatty acids and fatty acid metabolites (Reddy and Hashimoto, 2001 ). PPARα and its agonist stimulate hepatic peroxisome proliferation in response to high levels of dietary lipid, and PPARγ directs adipocyte differentiation (Reddy and Hashimoto, 2001) . RARs, RXRs, and PPARs add another layer to the effects of endocrinedisrupting compounds and provide a link between peripheral metabolism and ingestive behavior (Auwerx, 1999) .
How can adipocyte differentiation result in changes in ingestive behavior? Adipose tissue is not simply one uniform organ, but rather has at least three types based on the concentration of mitochondria. WAT has a low concentration of mitochondria in the cytoplasm, hence its white color. BAT has the highest concentration of mitochonodria, and beige or gray adipose tissue has an intermediate concentration of these cellular organelles. The relative proportions of these adipocyte types determine the metabolic rate and overall energy expenditure; the more gray and brown fat, the higher the level of fuel oxidation (reviewed by Bloor and Symonds, 2014) . In addition, different types of adipose tissue are distributed into the different regions of the body. The WAT around the visceral organs has direct circulatory communication with the gut, liver, pancreas and reproductive organs, is prone to proliferate during the development of insulin resistance, and produces more inflammatory cytokines. BAT and gray fat is located in subcutaneous depots, and is not associated with symptoms of metabolic syndrome. Thus, PPARγ, by virtue of its role in directing adipocyte differentiation and whether or not the cells become white, brown, or beige, can potentially control the adult body fat distribution, the rate of accumulation of visceral fat, limits of fatty acid oxidation, and other metabolic sequelae of body fat distribution.
Steroids and endocrine disruptors act via ligand-dependent transcription factors, such as PPARγ, to influence energy balance and obesity. For example, tributylin chloride (TBT) is a member of a class of compounds known as organotins, tetravalent tin compounds found in marine paints and industrial water works. Its mode of action differs with dose. At low doses, TBT can activate RXR and PPAR to directly modulate the activity of genes involved at multiple stages of adipocyte differentiation. At high doses, TBT can inhibit aromatase activity and thereby decrease estradiol synthesis and down-regulate ER in some tissue, while upregulating aromatase in other tissues. At doses that fall between these high and low doses, TBT inhibits the activity of corticosteroid 11-β-hydroxysteroid dehydrogenase, leading to decreased inactivation of cortisol, thereby increasing local glucocorticoid levels ( Figs. 1  and 2 ). Elevated glucocorticoid levels, acting at late stages of fetal development can alter adipocyte differentiation (Grun and Blumberg, 2006) . In Mus musculus, TBT is a ligand for RXR and PPAR, promotes adipogenesis in the murine 3T3-L1 cell model, and perturbs key regulators of adipogenesis in vivo. Prenatal exposure to TBT increases lipid accumulation in newborn mice and these effects persist into adulthood leading to larger gonadal fat pad weights. In Xenopus laevis, treatment with TBT, RXR, or PPAR increases the accumulation of gonadal fat (Grun and Blumberg, 2006) . These clear effects of TBT via RXR, PPAR, and steroid signaling pathways illustrate multiple routes of endocrine disruption leading to obesity (Figs. 1 and 2 ).
Linking peripheral metabolism to brain and behavior
It might seem that these peripheral effects of endocrine disruptors are independent of their central effects on the ARH circuits that control ingestive behavior. It is possible, however, that effects of steroids and endocrine disruptors on central feeding circuits are secondary to peripheral changes in energy expenditure, fuel oxidation, and lipogenesis. There is solid evidence that increased hunger for food and overeating can be affected by peripheral events that increase body fat storage and fuel oxidation (Friedman, 1990 (Friedman, , 1998 (Friedman, , 2008 Ji et al., 2005) . Furthermore, hunger and food intake are largely controlled by a metabolic sensory system, or an energostat, that monitors the overall availability of metabolic fuels, which in turn is a consequence of the flux of fuels into and out of storage (Friedman, 2008) . Food intake can be reliably increased by deficits in the cellular availability of fuels for oxidation, the process that provides energy for cellular work. Cellular fuel deficits can occur during starvation but also occur in the face of abundant food availability and/or high levels of body fat storage. An example occurs in diabetic rats fed a carbohydrate diet. Diabetic rats are hungry and hyperphagic because without insulin, they are unable to transport carbohydrate-derived fuels (glucose) into cells where they can be oxidized. The energostat registers a deficit in oxidizable fuels. This idea is supported by the fact that diabetic rats' hunger and hyperphagia are prevented when they are fed a high fat diet, which provides an alternative fuel (free fatty acids) that can be readily oxidized in the absence of insulin (Friedman, 1990 (Friedman, , 1998 (Friedman, , 2008 . Similarly, in obesity-prone individuals in whom body fat is accumulating, the increase in lipogenesis sequesters oxidizable fuels by transforming them into a chemical form that cannot be oxidized for cellular work (i.e., triglycerides stored in lipid droplets in adipocytes). In obesity-prone individuals therefore, a high proportion of fuels locked in storage and decreased fatty acid oxidation can lead to intense food craving and overeating of energy-dense foods. It is hypothesized that obesityprone individuals do not oxidize fat fuels as readily as obesityresistant individuals, and as a result tend to use these fuels in lipogenesis. The slow rate of fat oxidation in obesity-prone individuals leads to excessive accumulation of dietary fat in adipose tissue, which in turn leads to overeating in an attempt to compensate for the decreased availability of oxidizable fuels. This hypothesis has been supported by experiments in which obesity-prone and obesity-resistant rats were fed high-fat, obesity-inducing diets and treated with fenofibrate, a PPARα agonist that increases fatty acid oxidation (Staels et al., 1998) . This treatment significantly decreases food intake and body weight in obesity-prone, but not in obesity-resistant rats, suggesting that the treatment ameliorated the low fatty acid oxidation characteristic of obesity-prone rats (Ji et al., 2005) . This example provides one of the critical links between altered peripheral lipid disposition and central events that lead to changes in ingestive motivation and behavior. Whenever organizational effects of perinatal hormones on ingestive behavior are discovered, it is important to ask whether or not the effects are secondary to changes in energy expenditure and adipocyte morphology. This is not so much a "chicken and egg question" as a testable hypothesis.
Maternal programming of adult energy balancing traits
Another piece of the obesity puzzle is the large body of research on epigenetics and maternal programming of metabolism and cardiovascular health. The explosion of research in this area gives the impression that this is a new field of research, but in reality, it dates back to the mid 20th century. During the devastating famine that resulted from the German occupation of Holland in World War II known as the Dutch Hunger Winter, mothers who experienced starvation during the first two trimesters of pregnancy gave birth to sons with a significantly higher incidence of adult obesity compared to those of well-fed mothers (Ravelli et al., 1976) . Subsequently, other physicians and scientists noted effects of 1) adolescent nutrition on adult health, 2) maternal undernutrition on offspring health, and even 3) grandparents' nutrition with transgenerational effects on their grandchildren's adult health (Barker, 1997; Forsdahl, 1978; Lumey and Stein, 1997) . Most of these latter studies concerned cardiovascular health and diabetes, but they set the stage for examination of maternal programming of body weight and adiposity.
Using laboratory rats as a model system, Jones and Friedman, 1982 and Jones et al. (1984 , 1986 tested the hypothesis that maternal food restriction during the first two weeks of pregnancy programs obesity in the offspring. They found that male, but not female offspring of food-restricted mothers gained weight and became obese as adults, whereas the females showed disordered adipose tissue cellularity. Obesity was exaggerated in male offspring fed a calorically dense diet, and diet-induced obesity occurred without increased caloric intake, implicating changes in energy metabolism and lipogenesis. These results from behavioral endocrinology experiments of the 1980s are rarely recognized by researchers in the fields of obesity, diabetes, and cardiology, but now, we know from many subsequent studies that energy metabolism is profoundly influenced by the experiences of the mother, including her diet, exercise requirements, ambient temperature, and many other environmental stressors. In rats, mice, and sheep, prenatal calorie or protein restriction leads to low birth weight, usually followed by a period of rapid "catch-up" growth and body fat deposition, followed by adult obesity (Armitage et al., 2004; Bol et al., 2009; Bouret, 2010; de Oliveira et al., 2012; Holemans et al., 2003; McMillen et al., 2005; Ross and Desai, 2005; Symonds et al., 2004; Vickers et al., 2003) . Prenatal undernutrition in pregnant women leads to low birth weight newborns. If these babies are allowed to eat as much as they want, they gain weight rapidly during lactation. Catch-up growth is exaggerated in formula-fed compared to breast-fed babies, and both groups from undernourished mothers are prone to develop metabolic syndrome, insulin resistance, cardiovascular disease, and obesity as adults (Desai et al., , 2007 Eriksson et al., 1999) .
In some, but not all model systems, the effects on obesity and cardiovascular disease occur in offspring of both undernourished and overnourished mothers (Armitage et al., 2004; Symonds and Gardner, 2006; Vickers et al., 2000) . In nonhuman primates such as the Japanese macaque, mothers fed a high fat diet overeat, gain body fat, and give birth to offspring that develop altered expression of genes that encode putative orexigenic and anorectic peptides, increased circulating cortisol concentrations, and increased proinflammatory signals. Furthermore, as adults the offspring develop preferences for high fat diets (reviewed by Wilson et al., 2014) . Furthermore, the obesity of offspring of overnourished mothers can influence the subsequent generations (Lumey and Stein, 1997; Sullivan et al., 2014; Taylor and Poston, 2007) . It might seem paradoxical that both undernutrition and overnutrition have a similar effect on offspring. This is less surprising when we remember that some organisms that are predisposed to excess lipogenesis also experience a deficit in the availability of oxidizable fuels that can lead to overeating. As explained earlier in this review (see the section on "Linking peripheral metabolism to brain and behavior), having an abundance of adipose tissue and lipids stored inside adipocytes is not the same as having an abundance of oxidizable fuels readily available for cellular work.
This line of research is promising, yet, we seem to have lost sight of the original finding in rats (Jones and Friedman, 1982) , which included a profound sex difference: The susceptibility to diet-induced obesity in rats occurred mainly in the male pups of mothers food restricted during the first two weeks of pregnancy, whereas in female pups, there were changes in adipocyte architecture but not in the propensity for dietinduced obesity. This suggests that the field of maternal programming must meld with the study of sexual differentiation.
In fact, adult exposure to a calorically-dense diet in adulthood, perinatal androgen exposure, and maternal undernutrition all have similar effects on cardiovascular health embodied by what is referred to as "the metabolic syndrome"; all three produce enlarged mesenteric adipocytes, an atherogenic lipid profile, insulin resistance, hyperglycemia, and a predisposition to overeat a calorically-dense diet (Demissie et al., 2008; Manikkam et al., 2004) . Furthermore, maternal energy balance and prenatal testosterone interact to amplify the masculinization of the luteinizing hormone-surge system (Steckler et al., 2009) . Thus, it is important to ask whether maternal energy availability interacts with prenatal hormones to change adult energy balance.
Understanding the mechanisms of sexual differentiation will be imperative to understanding maternal programming, because these processes overlap. Just as energy balancing characteristics can be programmed by perinatal steroid action, they can be similarly affected during perinatal development by other hormones originating from the fetus. Some of these hormones respond to the availability of oxidizable fuels or modulate the availability of those fuels, including leptin (Bouret et al., 2004b window of ARH development (postnatal days 4-12), the deficits in ARH projections are fully reversed and the obesity is ameliorated (Bouret et al., 2004b) . The same treatment in adult Lep ob /Lep ob mice fails to affect ARH projections, suggesting that leptin acts neonatally as a neurotrophic factor to determine the fate of these particular neural structures involved in adult energy balance. If the process whereby leptin organizes ARH projections is analogous to the process whereby gonadal hormones organize the neural substrates for male-and female-typical sex behaviors, then perinatal leptin surges might render the brain more sensitive to adult effects of leptin, and this effect might be sex-specific. This has not been directly tested to the best of our knowledge. In fact, in the above-mentioned study, it is not clear whether the subjects were male or female. In the online supplementary material it is specified that males were used in the control group, but the sex of the experimental animals was not specified. In a parallel study, males and females were not different, and were thus combined into age groups in order to characterize the temporal sequence of development of ARH projections. In another part of the study aimed at understanding ARH activation in response to leptin treatment, the sexes were not shown separately (Bouret et al., 2004a) .
We now know that organizational effects occur in adults. In adult brains, short-term reversible effects involve restructuring, death, and rebirth of neurons (Kokoeva et al., 2005; McNay et al., 2012) . This is true with regard to hormonal remodeling of putative energy balancing systems of the ARH. In adult mice, for example, central leptin treatment can rapidly rewire the POMC circuitry in terms of the ratio of excitatory to inhibitory synapses on neuropeptide Y and POMC-containing cells in the ARH (Pinto et al., 2004 ). What's more, and relevant to this review, these rapid rewiring effects are mimicked by estradiol, even in Lep ob / Lep ob mice. Like the effects of leptin, the effects of estradiol on synaptic rewiring occur via STAT3 signaling (Gao et al., 2007) . This provides a quantifiable locus for investigation, i.e., a structural component of the nervous system where estradiol, leptin, and energy availability interface during sexual differentiation/fetal programming. Furthermore, it implicates estradiol as an agent capable of acting in the absence of leptin but via the STAT3 system to rewire circuits in the ARH (Fig. 3) . These experiments provoke other interesting questions. Can perinatal leptin ameliorate obesity in ER knockout mice? How does prenatal leptin action affect later response to adult leptin, ghrelin, testosterone, estradiol, or progesterone? Is perinatal leptin acting as an active feminizing agent in the manner of postnatal estradiol, or as a masculinizing agent in the manner of prenatal estradiol and testosterone? Which comes first, organization of the brain or periphery? Do early hormonal effects produce energetic deficits similar to those produced by maternal food restriction? Does maternal food restriction cause changes in perinatal hormones or sensitivity to hormones?
Epigenetics and transgenerational effects on energy balance
Effects of natural transcription factors and endocrine disruptors can have transgenerational effects, i.e., outcomes that are inherited from parent to offspring in successive generations. Two ways that this might occur are by imprinted germline epimutations and by genetic Fig. 3 . A Venn diagram of the interface of sexual differentiation, endocrine disruptor action, and maternal programming of energy balancing traits. At interface A, perinatal hormones program fetal energy balance, and the effects of hormones differ with the mother's energy balance. Furthermore, both maternal programming and sexual differentiation might have different effects depending on the genetic sex of the fetus. At interface B, both endogenous hormones and endocrine disruptors that mimic hormones, bind to steroid receptors and either masculinize, defeminize, or actively feminize energy balancing traits. At interface C, endocrine disruptors enter the mother and cross the placenta to alter effects of the mother's energy balance on the fetus. At the three-way interface D, there are many possibilities, e.g., both estradiol and leptin are secreted by the fetus and the mother, and both can act via STAT3 signaling to organize energy balancing circuits perinatally, and being vulnerable to estradiol, these circuits might also be vulnerable to estrogenic endocrine disruptors such as DES, DDT, or BPA. One interesting question is whether altered sexual differentiation by endocrine disruptors differs with maternal energy availability. accommodation, two processes that can change population phenotypic distribution without changing DNA (deoxyribonucleic acid) sequences. Epigenetic transgenerational effects are inherited via germline epimutations, a change in gene expression that does not alter the basepair sequence of the DNA (reviewed by Skinner et al., 2011) . These changes in gene expression are passed from parent to offspring and can lead to adaptive or maladaptive changes in physiology and behavior. As with the endocrine-disrupting compounds discussed already, those that cause epigenetic transgenerational effects have sexspecific effects that depend on the developmental stage of the subject. The mechanisms involve sex-specific DNA methylation. Thus, endocrine disruptors that mimic ligand-dependent transcription factors might have germline epigenetic effects on energy balancing traits, which might ultimately increase the rate of phenotypic change over generations. For example, fetal exposure to TBT (with endocrine disrupting potential via PPARγ) increases adipose tissue weight, adipocyte number, and adipocyte size, reprograms multipotent mesenchymal stromal stem cells to favor the adipogenic lineage at the expense of the osteogenic lineage, induces hepatic lipid accumulation, and upregulates the expression of genes involved in lipid storage, transport, and lipogenesis in the F 1 -F 3 generation offspring to TBT treated mothers (ChamorroGarcia et al., 2013) . In another study, fetal exposure to a mixture of BPA and two other estrogenic plastic-derived endocrine disruptors, bis(2-ethylhexyl)phthalate (DEHP) and dibutyl phthalate (DBP), caused obesity and testis disease in males, and primary ovarian insufficiency and polycystic ovaries in the F 3 generation female offspring . These effects were sex-and generation-specific. The incidence of testis disease in males and the ovarian disease in females was highest in the F 3 generation. Obesity was significantly increased in the F 3 generation females descended from the endocrine-disruptor treated subjects, but in F 3 males this only reached the level of a statistical trend. Furthermore, female obesity was not observed in the directly exposed F 1 generation, but only in the F 3 generation . In summary, transient exposure to these agents during a brief perinatal time window had marked effects on the F 3 generation.
Another process that induces transgenerational population change is known as genetic accommodation, a process that is generally adaptive (West-Eberhard, 2003) . It has long been suspected that novel environmental stressors initiate the transcription of heretofore untranscribed genes, thereby increasing genetic variability that has been hidden in the previous, less stressful environment. Hidden or "cryptic" genetic variation is genetic variation that is absent when measured under natural conditions, but is revealed under special circumstances, e.g., when a population runs out of its usual food source and survives by eating a novel food. When new variation is revealed, new opportunities emerge. Newly revealed genetic variation provides the fresh possibility that at least some of the new phenotypes will be adaptive for consuming the novel resource. If one or some of the newly revealed phenotypes are adaptive, selection can shift the frequencies of the phenotype rapidly in a process known as genetic accommodation (West-Eberhard, 2003) . Thus, the unmasking of cryptic genetic variation can lead to rapid phenotypic changes over only a few generations. Now there is evidence that genetic accommodation can happen with regard to energy balancing traits, and that genetic accommodation can be mediated by changes in diet and/or increases in stress hormones (Ledon-Rettig et al., 2010) . Tadpoles of spadefoot toads of the genus Spea have been used to demonstrate the presence of cryptic variation. Ledon-Rettig et al. (2010) hypothesized that environmental changes, such as the availability of a particular macronutrient, can increase glucocorticoids or its receptors, induce novel patterns of gene transcription, increase genetic variability, and create changes in gene frequencies that underlie phenotypes related to ingestive behavior (e.g., gut length, developmental speed, and growth rate). They noticed that most species of spadefoot toad subsist entirely on plants and detritus, whereas other, newer species catch and eat live animal prey, and wondered whether the change to a carnivorous diet might have involved genetic accommodation. Genetic variability in a suite of ingestive traits was compared in different groups of plant/detritus-eating tadpoles. Broad-sense heritabilities (amount of total genetic variance) were compared in 1) tadpoles fed ancestral (plant/detritus) diets, 2) tadpoles fed carnivorous diets, or 3) tadpoles fed the ancestral diet and treated with exogenous corticosterone. In the species used as a proxy for the ancestral species, Scaphiopus couchii, the carnivorous diet and corticosterone treatment significantly increase the genetic variance in traits related to ingestion. Thus, both the new diet and the increase in stress hormones can unmask genetic variation in a population, presumably allowing transgenerational changes that would not have occurred otherwise.
Though both treatments increased genetic variation, the nature and direction of the change in genetic variation differed between these two treatments. One possibility to explain the difference between the carnivorous diet and the corticosterone treatment is that hormonal effects differ depending on the energetic or nutritional background. Hormonal interaction with energy availability might have played a critical role in rapid population changes over generations (Ledon-Rettig et al., 2010) .
If diet changes and glucocorticoids can unmask cryptic genetic variation in toads, might changes in human diets and exposure to endocrine disruptors over the course of evolution also induce new genetic variability leading to rapid changes in energy balancing phenotypes? Can endocrine disruptors acting through glucocorticoid or other receptors also unmask cryptic variation? Alternatively or in addition, have endocrine disruptors had widespread transgenerational epigenetic effects that led to rapid population changes in energy balancing phenotypes? It is plausible that endocrine disruptors are altering or guiding the rate of change in traits related to diabetes and obesity. The startling implication is that might underlie the sharp increase in the incidence of obesity and metabolic syndrome, not by acting on adults, but by acting on the developing offspring, changing gene expression, exposing hidden genetic variation, thereby accelerating the rate of phenotypic change over generations.
This might also provide a partial explanation for the finding that laboratory rodents that were switched from traditional laboratory diets containing high levels of phytoestrogens to a phytoestrogen-free diet become obese (Ruhlen et al., 2008) . Until recently, all commercial laboratory chow diets are produced with soy as the primary ingredient, which contains high levels of phytoestrogens. Scientists interested in the effects of estradiol on various physiological and behavioral traits have recently switched to phytoestrogen-free diets in order to control for steroid exposure in their experimental and control groups. The unexpected result, however, was the development of obesity and various reproductive abnormalities in the control animals fed the phytoestrogen-free diets. This phenomenon suggests that, as soy-based laboratory rodent chows have become the norm, laboratory populations of animals have become adapted to regular exposure to endocrine disrupting phytoestrogens, and thus, when experimenters attempt to exercise control of estrogenic exposure by feeding phytoestrogen-free diets, their animals experience abnormalities related to energy balance and reproduction. The ubiquity of soybased products in standard laboratory chow occurred in a relatively short time frame (by evolutionary standards), but the phenomenon of transgenerational epimutations and genetic accommodation provides a mechanism that might account for these rapid population shifts.
The focus by Ledon-Rettig on genetic variation in characteristics of the gut may be prescient in that it encompasses new data demonstrating effects of gut flora on energy balance (Turnbaugh et al., 2006) . Endocrine disruptors and perinatal steroids can influence the favorability of the gut environment for proliferation of obesogenic versus obesoresistant microorganisms (Lalles, 2012) . Adaptation of laboratory species to phytoestrogen-containing diets might involve changes in populations of microorganisms that inhabit the gut and influence energy storage and expenditure.
The above considerations are admittedly speculative, but more importantly, they lead to valuable hypotheses that can be tested if we merge the concepts of sexual differentiation to the study of epigenetics/maternal programming of energy balance by dietary, energetic, and environmental endocrine factors.
Summary, conclusions, and future directions
We have provided evidence that genetics, diet, and sedentary behavior cannot fully explain the sharp rise in human obesity that occurred in the last century, and bring attention to the interface of endocrine disruptors in the environment, maternal programming, and sexual differentiation as a factor that underlies the rising incidence of obesity (Fig. 3) . The foundation for this assertion is based on four main pieces of evidence. The presence of endocrine disrupting compounds has been on the rise since the end of Word War II; these compounds are now ubiquitous in the environment (Baillie-Hamilton, 2002; Colborn et al., 1993; Simonich and Hites, 1995) ; and they have a plethora of effects on energy balancing systems (Heindel, 2003; Mackay et al., 2013; Newbold et al., 2005; Oken and Gillman, 2003; Ruhlen et al., 2008; Vom Saal et al., 2012) . Furthermore, energy balancing phenotypes are sexually dimorphic in humans, and the masculine phenotype is most closely linked to metabolic diseases such as type II diabetes and heart disease (Bonora, 2000; Kotani et al., 1994; Lemieux, 2001; Macotela et al., 2009; Wajchenberg, 2000) . Finally, endocrine disruptors have masculinizing effects on sexually dimorphic phenotypes, and might also act through other defined mechanisms of sexual differentiation, such as active feminization.
The inextricable link between energy balance and reproduction is well known and has been the topic of many reviews in the past three decades (Schneider et al., 2012; Schneider et al., 2013; Wade and Jones, 2004; Wade and Schneider, 1992) . If endocrine disruptors interfere with processes involved in reproduction, it follows that they might interfere with those involved in energy balance. Each endocrine disruptor is likely to have different effects depending on whether it agonizes or antagonizes growth hormone, estrogen, androgen, or glucocorticoid receptors ( Figs. 1 and 2 ). These in turn might occur via the different types of steroid action: classical, genomic; nonclassical, nongenomic; and nonclassical, genomic hormone actions. In fact, in this review, we provided a few concrete examples demonstrating that the effects of endocrine disruptors on energy balancing traits involve masculinization, active feminization, aromatization, and hormone action at multiple critical periods.
Investigators that study the effects of endocrine disruptors on peripheral processes often work in isolation from investigators that study the neural circuits for ingestive behavior. Examples were provided in this review to illustrate that peripheral changes, such as agonism of PPARs, lead to changes in ingestive behavior (Ji et al., 2005) . Future work should take up the search for the energostat, and design experiments to determine whether endocrine disruptors might influence the development of hyperphagia, high caloric diet-induced obesity, and metabolic syndrome via ligand-dependent transcription factors involved in fatty acid oxidation and lipogenesis.
New information on the epigenetic effects of endocrine disruptors, their overlap with fetal programming, and their potential for unmasking cryptic genetic variation provide a plausible basis for hypothesizing that endocrine disruptors are responsible for the rapid increase in obesity at the end of the last millennium. This perspective melds ideas from the sciences concerned with the most proximate with those concerned with the most ultimate causes of physiology and behavior. Leaders in the field of neuroendocrinology agree that understanding the significance of endocrine disruptors requires collaborative efforts that blend the knowledge and expertise of many biological disciplines and government agencies Crews and Gore, 2011; Gore et al., 2014; Vandenberg et al., 2013; Zoeller et al., 2012) . The authors of this review concur with this perspective and extend it to include experts in neuroendocrinology of ingestive behavior, energy balance, and obesity.
